Properties of four acute phase proteins: C-reactive protein, serum amyloid a protein, α1-acid glycoprotein, and fibrinogen

Seminars in Arthritis and Rheumatism

Volumn 20, Issue 3, 1990, Pages 129-147

  Schultz, Duane R ^a   Arnold, Patricia I ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase proteins; C reactive protein; fibrogen; serum amyloid A protein; 1 acid glycoprotein

Indexed keywords

AMYLOID PROTEIN; C REACTIVE PROTEIN; FIBRINOGEN; OROSOMUCOID;

AMYLOIDOSIS; ARTICLE; COMPLEMENT ACTIVATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; AMYLOID PROTEIN AA; ANIMAL; C-REACTIVE PROTEIN; CYTOKINES; FIBRINOGEN; HUMAN; OROSOMUCOID;

EID: 0025553450     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(90)90055-K     Document Type: Article

References (173)

1. The phenomenon of the acute phase response
2. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein
3. The acute phase response is mediated by heterogeneous mechanisms
4. The liver as the site of C-reactive protein formation
5. Radioimmunoassay of human C-reactive protein and levels in normal sera
6. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response
7. IFN β2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes
8. Recombinant human interleukin 6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes
9. Interleukin 6. The major regulator of acute-phase protein synthesis in man and rat
10. Multiple actions of interleukin 6 within a cytokine network
11. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus
12. The occurrence during acute infections of a protein not normally present in the blood I Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus
13. The occurrence during acute infections of a protein not normally present in the blood II Isolation and properties of the reactive protein
14. Historical perspectives on C-reactive protein
15. C-reactive protein. A historical overview
16. C-reactive protein: A molecule composed of subunits
17. Characterization of C-reactive protein and the complement subcom ponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins)
18. Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1
19. Primary structure of human C-reactive protein
20. Genomic DNA sequence for human C-reactive protein
21. Isolation of human C-reactive protein cDNA and localization of the gene to chromosome 1
22. The human C-reactive protein gene (CRP) and serum amyloid P component gene (APeS) are located on the proximal long arm of chromosome 1
23. Identification of sequences responsible for acute-phase induction of human C-reactive protein
24. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide
25. Phylogenetic aspects of C-reactive protein and related proteins
26. Studies on the binding specificity of human C-reactive protein for phosphorylcholine
27. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate
28. Pneumococcal Forssman antigen, a choline-containing lipoteichoic acid
29. Binding activity of C-reactive protein for polycations
30. Isolation and characterization of guinea pig serum amyloid P component
31. Limulin: A C-reactive protein from Limulus polyphemus
32. C-reactive protein fifty years on
33. Biology of C-reactive protein and the acute phase response
34. Effect of human serum and some of its components on neutrophil adherence and migration across an epithelium
35. Effect of C-reactive protein on normal human leukocytes
36. Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells
37. Peripheral blood mononuclear leukocytes release a mediator(s) that induces phagocytosis of C-reactive protein coated cells by polymorphonuclear leukocytes
38. Binding of C-reactive protein to human polymorphonuclear leukocytes evidence for association of binding sites with Fc receptors
39. Binding of C-reactive protein to human neutrophils
40. Modulation of human neutrophil function by C-reactive protein
41. Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing Fc receptor
42. C-reactive protein is produced by a small number of normal peripheral blood lymphocytes
43. Human lymphocytes synthesize C-reactive protein
44. Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors
45. Binding sites for C-reactive protein on human monocytes are distinct from IgG Fc receptors
46. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis
47. Enhancement of human peripheral blood monocyte respiratory burst activity by aggregated C-reactive protein
48. Aggregated C-reactive protein binds to human polymorphonuclear leukocytes and potentiates Fc receptor-mediated chemiluminescence
49. Human monocytes and U937 cells bear two distinct Fc receptors for IgG
50. Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes
51. Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors
52. Specific binding of human C-reactive protein to human monocytes in vitro
53. Degradation of a pneumococcal Type-specific polysaccharide with exposure of group-specificity
54. Antigalactan and anti-haemocyanin specificity of CRP
55. Interaction of C-reactive protein with artificial phosphatidyl choline bilayers and complement
56. C-reactive protein binds Leishmanial excreted factors
57. Carbohydrate-specific receptors of the liver
58. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins
59. A membrane-associated form of C-reactive protein is the galactose-specific particle receptor on rat liver macrophages
60. C-reactive protein is protective against Streptococcus pneumoniae infection in mice
61. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice
62. Blood clearance of Streptococcus pneumoniae by C-reactive protein
63. Human C-reactive protein and host defence
64. Antipneumo-coccal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens
65. In vivo studies of serum C-reactive protein turnover in rabbits
66. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and spingomyelin
67. Interactions of C-reactive protein with the first component of human complement
68. Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanions and polycations in the presence of C-reactive protein
69. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations
70. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumonia
71. The role of immunoglobulin in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway
72. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide
73. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway
74. C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro
75. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis
76. The membrane attack complex
77. The chemistry and biology of complement receptors
78. Structure and function of the anaphylatoxins
79. Localization of C-reactive protein in the synovium of patients with rheumatoid arthritis
80. The presence and possible significance of C-reactive protein in rheumatoid inflammation
81. Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect of synovial fluid lymphocyte subsets and inflammatory indices
82. Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and non-inflammatory arthritis
83. Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein
84. Functional effects of C-reactive protein binding to nuclei
85. Analysis of the binding of C-reactive protein to histones and chromatin
86. Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein
87. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis
88. Macrophage tumoricidal activity induced by human C-reactive protein
89. Platelet agonist synergism by the acute phase reactant C-reactive protein
90. C-reactive protein -(CRP) mediated modulation of human B cell colony development
91. C-reactive protein reduces the promotion of human B-cell colony formation by autoreactive T4 cells and T-cell proliferation during the autologous mixed lymphocyte reaction
92. Proteolysis of human C-reactive protein produces peptides with potent immunodulating activity
93. Synthetic peptides from C-reactive protein containing tuftsin-related sequences
94. The covalent structure of an entire gamma G immunoglobulin molecule
95. Tuftsin: A natural phagocytosis stimulating peptide
96. Immunologic studies of the major nonimmunoglobulin protein of amyloid I Identification and partial characterization of a related serum component
97. The acute phase reactants and the erythrocyte sedimentation rate
98. Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites
99. 1) from human high density lipoprotein
100. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences
101. Heterogeneity of human serum amyloid A proteins
102. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture
103. Serum amyloid A and high density lipoproteins during the acute phase response
104. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms
105. Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of pre-SAA and structural variants denned by complementary DNA
106. Reactive (secondary) amyloid and its protein precursor
107. The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences
108. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo
109. AA amyloidosis in systemic lupus erythematosus
110. Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus
111. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis
112. Presence of glycoaminoglycans in purified AA type amyloid fibrils associated with juvenile rheumatoid arthritis
113. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
114. Serum amyloid A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis
115. Variation with age and disease of an amyloid A protein-related serum component
116. Amyloid-related serum component (SAA)-studies in acute infections, medullary thyroid carcinoma, and postsurgery
117. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease
118. Serum amyloid A: an extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute response in various diseases
119. Serum amyloid protein A (SAA): an indicator of inflammation in AIDS and AIDS-related complex (ARC)
120. Comparative study of serum amyloid A protein and C-reactive protein in disease
121. Amyloid related serum protein (SAA) as an indicator of lung infection in cystic fibrosis
122. Studies on the mucoproteins of human plasma. I. Determination and isolation
123. Studies on the mucoproteins of human plasma II Plasma mucoprotein levels in cancer patients
124. Comparative studies of serum polysaccharides in rheumatoid arthritis and degenerative joint disease
125. Studies on the mucoproteins of human plasma. V. Isolation and characterization of a homogeneous mucoprotein
126. Preparation and properties of an acid glycoprotein prepared from human plasma
127. 1-acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins
128. 1-acid glycoprotein-Biochemical properties, the amino acid sequence and the structure of the carbohydrate moiety, variants and polymorphism
129. α, β, γ, ω- the roster of the plasma proteins
130. 1-acid glycoprotein
131. 1-acid glycoprotein and the immunoglobulins
132. 1-acid glycoprotein by 360 MHz'H NMR spectroscopy and permethylation analysis
133. 1-acid glycoprotein (orosomucoid) variants
134. Subtyping of orosomucoid 1 by isoelectric focusing in agarose and polyacrylamide gels
135. Orosomucoid (ORM) typing by isoelectric focusing: evidence for gene duplication of ORM1 and genetic polymorphism of ORM2
136. Orosomucoid 1 and orosomucoid 2 types in the Taiwanese and Japanese: Evidence for 5 new orosomucoid variants
137. Mannose/glucose binding lectins
138. On the significance of heterogeneity of plasma glycoproteins possessing N-glycans of the complex type A perspective
139. 1-acid glycoprotein. A method for determining the degree of sialylation of serum glycoproteins
140. δ-aminoleuvulinate dehydrase: synteny with ABO, AK1, ORM and assignment to chromosome 9
141. 2HS-glycoprotein to chromosome 3 using human fetal liver × rat hepatoma hybrids
142. Structure and expression of the genes coding for human AAG
143. 1-acid glycoprotein genes in cultured cells and in transgenic mice
144. 1-acid glycoprotein in health and disease
145. 1-acid glycoprotein populations of different pi values after Concanavalin A affinity chromatography: Study of their evolution during inflammation in man
146. Microheterogeneity of orosomucoid in pathological conditions
147. Microheterogeneity forms of alpha-1-acid glycoprotein as indicators of rheumatoid arthritis activity
148. Microheterogeneity of alpha-1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus
149. Microheterogeneity of α-1-acid glycoprotein in the detection of intercurrent infection in patients with rheumatoid arthritis
150. Serum IgA, acute phase proteins, and glycosylation of α 1-acid glycoprotein in ankylosing spondylitis
151. Monokines regulate glycosylation of acute-phase proteins
152. 1-antitrypsin
153. 1-acid glycoprotein in rheumatoid arthritis
154. 1-acid glycoprotein: Importance of the carbohydrate moiety
155. 1-acid glycoprotein, with the lymphoid cell surface: A model for nonspecific immune suppression
156. Lymphocyte stimulation in vitro by orosomucoid glycoprotein
157. Human alpha-1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity
158. 1-acid glycoprotein
159. Fibrinogen and fibrin
160. Sequential changes of plasma proteins after surgical trauma
161. The effects of leukocytic and serum factors on fibrinogen biosynthesis in cultured hepatocytes
162. An in vitro bioassay for leukocytic endogenous mediator(s) using cultured rat hepatocytes
163. In vitro synthesis of rat fibrinogen: Identification of pre Aα, preBβ, and pre γ polypeptides
164. Hepatoma cell lines can be induced to synthesize a family of acute-phase plasma proteins by a monocyte-derived stimulating family
165. Induction of fibrinogen and a subset of acute phase response genes involves a novel monokine which is mimicked by phorbol esters
166. Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines Comparison with interleukin 1
167. Acute phase reaction, fibrinogen level and thrombus size
168. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen
169. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen
170. Methods for the study of acute-phase reactants
171. Complement activation induced by human C-reactive protein in mildly acid conditions
172. Peptides generated from C-reactive protein by a neutrophil membrane protease